Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes (MDS)

Showing 26 - 34 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS (MDS), Quality of Life, Red Blood Cell (RBC) Transfusions Trial in Hamilton, Toronto (Red Blood Cell Transfusions)

Unknown status
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Red Blood Cell Transfusions
  • Hamilton, Ontario, Canada
  • +2 more
Apr 24, 2018

Leukemia, Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Stanford (Azacitidine, Lenalidomide)

Terminated
Has Results
  • Leukemia
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Dec 4, 2017

MDS (MDS) Trial in China (decitabine)

Unknown status
  • Myelodysplastic Syndromes (MDS)
  • Nanning, Guangxi, China
  • +5 more
Nov 7, 2017

Anemia, Leukemia, Acute Myeloid Leukemia (AML) Trial in Stanford (Lenalidomide)

Terminated
Has Results
  • Anemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jun 27, 2017

MDS (MDS), Acute Myeloid Leukaemia (AML) Trial in East Melbourne, Malvern (Azacitidine and eltrombopag)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Acute Myeloid Leukaemia (AML)
  • Azacitidine and eltrombopag
  • East Melbourne, Victoria, Australia
  • +1 more
Feb 12, 2016

B-Receptor Signaling in Cardiomyopathy

Completed
  • Carcinomas
  • +37 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 16, 2015

    Blood Cancer, MDS, MDS (MDS) Trial in Stanford (Darbepoetin alfa)

    Completed
    • Blood Cancer
    • +2 more
    • Darbepoetin alfa
    • Stanford, California
      Stanford University School of Medicine
    Jan 31, 2013

    Acute Disease, MDS, Leukemia, Myeloid, Chronic Trial in Stanford (ablative allogeneic hematopoietic cell transplantation)

    Completed
    • Acute Disease
    • +6 more
    • ablative allogeneic hematopoietic cell transplantation
    • Stanford, California
      Stanford University School of Medicine
    Dec 13, 2012

    MDS, Myeloproliferative Disorders, Blood and Marrow Transplant (BMT) Trial in Stanford (nonmyeloablative allogeneic

    Completed
    • Myelodysplastic Syndromes
    • +4 more
    • nonmyeloablative allogeneic hematopoietic cell transplant
    • Stanford, California
      Stanford University School of Medicine
    Oct 13, 2010